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Abstract
N-acetylglucosaminyltransferase III (GnT-III) is known to catalyze N-glycan Bbisection^ and thereby modulate the formation of
highly branched complex structures within the Golgi apparatus. While active, it inhibits the action of other GlcNAc transferases such
as GnT-IV and GnT-V. Moreover, GnT-III is considered as an inhibitor of the metastatic potential of cancer cells both in vitro and
in vivo. However, the effects of GnT-III may be more diverse and depend on the cellular context. We describe the detailed glycomic
analysis of the effect of GnT-III overexpression in WM266–4-GnT-III metastatic melanoma cells. We used MALDI-TOF and ESI-
ion-trap-MS/MS together with HILIC-HPLC of 2-AA labeled N-glycans to study the N-glycome of membrane-attached and secreted
proteins.We found that the overexpression ofGnT-III inmelanoma leads to themodification of a broad range ofN-glycan types by the
introduction of the Bbisecting^GlcNAc residue with highly branched complex structures among them. The presence of these unusual
complex N-glycans resulted in stronger interactions of cellular glycoproteins with the PHA-L. Based on the data presented here we
conclude that elevated activity of GnT-III in cancer cells does not necessarily lead to a total abrogation of the formation of highly
branched glycans. In addition, the modification of pre-existing N-glycans by the introduction of Bbisecting^ GlcNAc can modulate
their capacity to interact with carbohydrate-binding proteins such as plant lectins. Our results suggest further studies on the biological
function of Bbisected^ oligosaccharides in cancer cell biology and their interactions with carbohydrate-binding proteins.
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Abbreviations
AA 2-aminobenzoic acid
Fuc, F fucose
Hex, H hexose
HILIC hydrophilic interaction liquid chromatography
HexNAc, N N-acetylhexosamine
mDCIR2 mouse dendritic cell inhibitory receptor 2
NeuAc, SA N-acetylneuraminic acid
NeuNAcLac lactonized N-acetylneuraminic acid
PAG pregnancy-associated glycoprotein
Introduction
Glycosylation is the most frequent and abundant post-
translational modification of membrane and secreted proteins
in Eukaryota. Because of their structural complexity, glycans
bear an enormous informational capacity, strongly enhance
the diversity of proteins, and thus can regulate cell biology
at many levels [1]. The N-glycosylation of proteins takes place
within the secretory pathway, which involves endoplasmic
reticulum (ER) and Golgi apparatus (GA). The formation of
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mature glycans attached to the consensus sequence within the
protein backbone is strongly dependent on the action of sev-
eral glycosylation enzymes (glycosidases and glycosyltrans-
ferases), the accessibility of activated monosaccharide donors
and the efficiency of their transportation into the lumen of ER
and GA [2]. Although the general orchestration of the glyco-
sylation machinery has been well described [3], the details of
the regulation of the process are still under investigation. One
of the most interesting aspects is the mutual relationship be-
tween glycosyltransferases within the Golgi apparatus.
N-Acetylglucosaminyltransferase III (GnT-III) is an en-
zyme acting within the medial-Golgi and is responsible for
the transfer of a single N-acetylglucosamine (GlcNAc) in a
β1,4 linkage to the β-mannose on N-glycans, thus forming
the Bbisecting^ GlcNAc structure. The presence of the
Bbisecting^ GlcNAc, which causes a characteristic conforma-
tional change of the glycan [4], has been recognized as inhib-
itory towards other GlcNAc transferases such as GnT-IV and
GnT-V, preventing the formation of highly-branched species,
such as the β1-6-GlcNAc branching catalyzed by GnT-V
[5–7]. Moreover, recent data show that overexpression of
GnT-III can dramatically suppress α2-3-sialylation at a post-
transcriptional level [8].
The action of GnT-III also has important implications in
cancer biology, since the transformation and progression of
many types of cancer are accompanied by changes in protein
glycosylation, some of which are considered cancer bio-
markers [9–11]. In this regard, GnT-III traditionally is pictured
as a suppressor of malignancy and there is much evidence that
overexpression of GnT-III inhibits the metastatic potential of
cancer cell both in vitro and in vivo [6, 12, 13]. This anti-
cancer effect of GnT-III activity is often attributed to the fact
that the presence of Bbisecting^ GlcNAc on membrane adhe-
sion proteins such as cadherins and integrins modulates their
function and thus influence adhesion relations between cancer
cells themselves as well as between cells and the extracellular
matrix proteins [14, 15]. Previous studies clearly show that
GnT-III activity promotes homotypic interactions of E-
cadherins on mammary carcinoma and melanoma cells [14,
16]. Downregulation ofMgat3 in the mouse model of PyMT-
inducedmammary carcinoma accelerates migratory properties
of cancer cells promoting the metastases to the lung [17].
Finally, it is known that introduction of Bbisecting^ GlcNAc
to integrins reduces cell migration [18]. The metastasis-
inhibitory effect of GnT-III, also in the context of adhesion
protein modulation is linked to its ability to inhibit the forma-
tion of highly branched N-glycans, especially β1-6-GlcNAc
branching with polylactosamine epitopes, which can promote
cell proliferation, migration and invasion [6]. However, the
picture of GnT-III as a universal metastasis modulator remains
controversial, as its elevated activity is observed in some ma-
lignancies such as hepatoma, ovarian cancer, multiple myelo-
ma and chronic myeloid leukemia [19–22]. These
observations suggest, that the GnT-III effect in cancer is more
complex, and may depend on the cellular context. Hence, its
impact on the repertoire of N-glycans on the cell surface and
on secreted proteins needs further study.
Melanoma is a highly invasive tumor, which can develop
within the skin, uvea and gastric mucosa [23]. Many studies
suggest the important role of β1-6-GlcNAc branched N-
glycans in the promotion of metastatic potential of melanoma
cells, mainly through the modulation of integrin-dependent
adhesion andmigration [24–27]. Recently, we have developed
an in vitro melanoma model in which we induced the overex-
pression of GnT-III in metastatic melanoma cell lineWM266–
4 [28]. In the present work, we have investigated the N-
glycosylation profile of membrane and secreted proteins of
these cells in detail, providing evidence that GnT-III upregu-
lation does not inhibit the formation of highly branched N-
glycans but efficiently modifies these glycans by the introduc-
tion of a Bbisecting^ GlcNAc.
Materials and methods
Reagents
Nonidet P40 was purchased from Roche (Warszawa, Poland).
Acrylamide, APS, bisacrylamide, 0.5 M Tris pH 6.8 buffer,
1.5 M Tris pH 8.8 buffer, Laemmli Sample Buffer, 2-
mercaptoethanol, TEMED, Tris-glycine buffer, Tris-glycine-
SDS buffer were procured from Bio-Rad (Warszawa, Poland).
PageRuler Prestained Protein Ladder was obtained from
Fermentas (Thermo Fisher Scientific, Warszawa, Poland).
DPBS and FBS were purchased from Life Technologies
(Warszawa, Poland). 2,5-dihydroxybenzoic acid (2,5-DHB)
was from Bruker Daltonics (Bremen, Germany). Acetonitrile
HPLC grade for far UV, 2-aminobenzamide (2-AB),
anthranilic acid (2-AA), sodium cyanoborohydride, DMSO
and trifluoroacetic acid (TFA) were purchased from Sigma-
Aldrich (Poznań, Poland). All other salts, alcohols and acids
were analytical grade chemicals from Sigma-Aldrich. Water
used was of Milli-Q grade.
Cells and culture conditions
As an experimental model, we used previously described
WM-266-4-GnT-III human metastatic melanoma cells, stably
overexpressing the MGAT3 gene together with mock control
cells WM-266-4-pIRESneo [28]. The cells were grown in
RPMI-1640 culture medium supplemented with 25 mM
HEPES and L-alanine-L-glutamine (RPMI-1640 Glutamax-
I; Gibco, Life Technologies), in the presence of standard anti-
biotic cocktail (100 μg/ml streptomycin, 100 U/ml penicillin;
Sigma-Aldrich) and 100 μg/ml G418 sulfate (Geneticin;
Gibco, Life Technologies) as a selection agent. Culture
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medium was supplemented with 10% fetal bovine serum
(Gibco, Life Technologies) and cells were grown with 5%
CO2 at 37 °C. Cells were systematically tested by PCR for
the presence of Mycoplasma sp.
Isolation of membrane and secreted proteins
Cells were grown until ~70% confluency, washed 5 times with
DPBS and then cultured in serum-free medium for 24 h. The
culture media containing secreted proteins were collected, fil-
tered through a 0.4 μm pore size syringe filter and frozen at
−70 °C. The cells were washed 3 times with cold DPBS, scraped
carefully with a rubber policeman in about 2 ml of cold DPBS
and centrifuged at 500×g for 10 min at 4 °C. The membrane
proteins were isolated using QProteome Cell Compartment Kit
(Qiagen, Hilden, Germany) according to manufacturer’s proto-
col and the obtained fractions were frozen at −70 °C.
Before electrophoresis and deglycosylation, the secreted
and membrane proteins were concentrated by precipitation.
Briefly, the collected conditioned media containing secreted
proteins were lyophilized, resuspended in a minimal volume
of 50 mM Tris-HCl, pH 8.0 containing 0.5% Triton-X-100
and dialyzed 3 times overnight against water. For protein pre-
cipitation, one part of secreted proteins suspension or mem-
brane protein fraction was mixed with 4 parts of methanol,
followed by 1 part of chloroform and 3 parts of water, with
mixing at each step. After centrifugation (15,000×g, 2 min),
the upper aqueous layer was removed, leaving the proteins
intact at the interphase. Then, 4 volumes of methanol were
added, and the precipitated proteins were spun down
(15,000×g, 2 min) and dried at room temperature (RT) under
the fume hood, after removal of the supernatant.
Polyacrylamide gel electrophoresis in presence of SDS
(SDS-PAGE)
Precipitated protein pellets were resuspended in Laemmli
sample buffer, and after heat denaturation (100 °C, 5 min)
the proteins were separated on 8% polyacrylamide gels, ac-
cording to Laemmli [29] in the presence of 0.1% SDS and
beta-mercaptoethanol. Molecular masses of proteins were de-
termined using a prestained protein ladder (Fermentas). After
electrophoresis, separated proteins were transferred onto an
Immobilon-P PVDF membrane (Merck Millipore,
Warszawa, Poland) overnight at 4 °C with a constant current
of 100 mA (Mini Trans-Blot Electrophoretic Transfer Cell;
Bio-Rad) according to Towbin et al. [30].
Lectin detection of blotted glycoproteins
The protein bands containing studied oligosaccharide epitopes
were detected according to Haselbeck et al. [31] with further
modifications made by Ochwat et al. [32]. PVDF membranes
with separated glycoproteins were blocked in 0.5% blocking
reagent (DIG Glycan Differentiation Kit; Roche Diagnostics,
Mannheim, Germany) in TBS for 2–3 h at RT. Blots were
washed twice in TBS-0.1% Tween 20 and once in lectin incu-
bation buffer. Membranes were incubated (1 h, RT) with fol-
lowing biotinylated lectins (Vector Labs, Burlingame, CA):
Phaseolus vulgaris erythroagglutinin (PHA-E), Phaseolus
vulgaris leucoagglutinin (PHA-L), Sambucus nigra agglutinin
(SNA), Maackia amurensis agglutinin (MAA), Galanthus
nivalis agglutinin (GNA) and Aleuria aurantia agglutinin
(AAA) (see Table 1). All lectins were diluted (1:4000) in
50 mM Tris-HCl, pH 7.5 containing 150 mM NaCl, 1 mM
MgCl2, 1 mM MnCl2, 1 mM CaCl2. After incubation with
lectins, membranes were washed (3 × 15 min) in TBS-0.1%
Tween 20 and incubated (1 h, RT) with ExtrAvidin-AP
(Sigma-Aldrich) diluted in TBS-0.1% Tween 20 (1:4000).
After another washing series (3 × 5 min in TBS-0.1% Tween
20; 3 × 5 min in TBS), lectin-reactive bands were visualized on
membranes after transformation of NBT and BCIP 4-toluidine
salt substrates (Roche Diagnostics) into colored products.
Isolation and labeling of glycoprotein derived
N-linked oligosaccharides
Precipitated proteins were resuspended in 20 μl of reducing
buffer (0.5% SDS, 1% 2-mercaptoethanol), denatured at
100 °C for 10 min and after cooling to RT, SDS was neutral-
ized by adding 4 μl of 10% NP-40. After that, 4 μl of 0.5 M
sodium phosphate buffer, pH 7.5 was added followed by 2 μl
of PNGase F (500,000 U/ml, New England Biolabs, Ipswich,
MA) and water up to 40 μl. The glycoprotein samples were
deglycosylated at 37 °C overnight. The released N-glycans
were desalted by solid phase extraction (SPE) on non-porous
graphitized carbon SPE columns (Grace, Alltech, Columbia,
MD) according to Packer et al. [33] and eluted glycans were
dried-down on SpeedVac. Next, samples were made up to
30 μl with water and the released oligosaccharides were la-
beled with anthranilic acid (2-AA) according to Anumula and
Dhume [34] modified by Neville et al. [35]. Fluorescently
labeled N-glycans were then purified on Spe-ed Amide-2
SPE columns (Pelican Scientific, Tattenhall, U.K.). The col-
umns were washed with 1 mL of ACN followed by 1 mL of
water and equilibrated with 2 mL of ACN. The samples were
diluted with 1 mL of 97% (v/v) ACN in water and loaded on
columns. After washing two times with 95% (v/v) ACN in
water the labeled N-glycans were eluted with 1.5 mL of water
and kept frozen at −20 °C.
Separation of charged and neutral N-glycans prior
the HPLC analysis
Negatively charged oligosaccharides were separated from
neutral species by SPE using anion exchange resin (QAE-
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Sephadex, Sigma-Aldrich, Poole, U.K.). 1 mL plastic mini-
columnswere loadedwith 200 μl of the resin and washedwith
2 mL of water. Aliquots of 2-AA labeled N-glycans were
loaded on columns and after washing with water the neutral
glycans were eluted with 0.5 M acetic acid and the charged
fraction with 0.5 M ammonium acetate. The neutrals were
purified by lyophilization and the charged species were
desalted using PGC SPE (HyperSep® HyperCarb®; Thermo
Fisher Scientific, Paisley, UK) according to Alonzi et al. and
dried under vacuum [36].
HPLC analysis of fluorescently labeled N-glycans
Purified 2-AA oligosaccharides were separated by NP-HPLC
using a 4.6 × 250 mm TSK gel-Amide 80 column (5 μm bead
size) (Anachem, Luton, Beds, U.K.) according to Neville et al.
[37]. The chromatography system consisted of Waters
Alliance 2695 separations module and an in-line Waters 474
fluorescence detector set at Exλ 360 nm and Emλ 425 nm. All
chromatography was performed at 30 °C. Solvent Awas ace-
tonitrile. Solvent B was Milli-Q water. Solvent C was com-
posed of 800 mM ammonium hydroxide, titrated to pH 3.85
with acetic acid, in Milli-Q water. Samples were loaded in
70%ACN and separated using gradient conditions as follows:
time = 0 min (t = 0), 71.6% A, 25.9% B, 2.5% C (0.8 mL/
min); t = 6, 71.6% A, 25.9% B, 2.5% C (0.8 mL/min); t = 45,
46.2% A, 51.3% B, 2.5% C (0.8 mL/min); t = 46, 35% A,
62.5% B, 2.5% C (0.8 mL/min); t = 48, 35% A, 62.5% B,
2.5% C (0.8 mL/min); t = 49, 71.6% A, 25.9% B, 2.5% C
(0.8 mL/min); t = 51, 71.6% A, 25.9% B, 2.5% C (1.2 mL/
min); t = 64, 71.6% A, 25.9% B, 2.5%C (1.2 mL/min); t = 65,
71.6% A, 25.9% B, 2.5% C (0.8 mL/min). All chromatogra-
phy was controlled, and data were collected and processed
using Waters Empower software, and the glucose unit values
were determined following comparison with a 2AA-labeled
glucose oligomer ladder external standard (Glyko Prozyme,
Hayward, CA).
MALDI-TOF(/TOF)-MS
Dried 2-AA labeled glycans were reconstituted in a minimal
volume of water and desalted using a C18 ZipTip™
(Millipore) following the manufacturer’s instructions.
Glycans were eluted with 1.5 μl of 2,5-dihydroxybenzoic acid
(10 mg/ml in 50/50, ACN/water containing 0.1% TFA) direct-
ly onto a MALDI target plate and dried at RT.
MALDI-TOF-MS was performed on UltrafleXtreme™
mass spectrometer controlled by FlexControl 3.1 software
(Bruker Daltonics, Bremen, Germany). The instrument was
externally calibrated using the Bruker peptides calibration
kit. The spectra were acquired both in the negative ion
reflectron mode and linear mode over the m/z range from
700 to 5000 for a total of 5000 shots.
LC-ESI-ion trap-MS/MS
Nano-liquid chromatography-tandem mass spectrometry
(nanoLC-MS/MS) was performed with the use of an
Ult imate 3000 LC system (Dionex, Amsterdam,
The Netherlands). Aliquots of the 2-AA labeled N-glycans
(1 μl) were applied to a C18 PepMap™ 0.3 × 5 mm trapping
column (Dionex) and washed with 100% solvent A (0.1%
formic acid in water and 0.4% ACN) for 10 min at a flow rate
of 25 μl/min. Next, AA-labeled glycans were separated on a
reverse phase analytical column (C18 PepMap 100 Å, 3 μm,
75 μm× 150 mm; Dionex) at a flow rate of 300 nl/min with
the UV detection. The mobile phase gradient was as follows:
0–25% eluent B (95% ACN, 5% water) in 15 min and 25–
Table 1 List of plant lectins used
in lectin blot assay Lectin
source
Binding specificity
SNA-I
Sambucus nigra
NeuNAcα2-6Gal-
NeuNAcα2-6GalNAc-
MAA-I
Maackia amurensis
NeuNAcα2-3Galβ1-4GlcNAc
PHA-L
Phaseolus vulgaris
Galβ1-4GlcNAcβ1-6(Galβ1-4GlcNAcβ1-2)Manα-
PHA-E
Phaseolus vulgaris
Galβ1-4GlcNAcβ1-2Manα1-4 (GlcNAcβ1-4)Manα-
GNA
Galanthus nivalis
Manα1-2Manα-
Manα1-6Manα-
Manα1-3Manα-
AAA
Aleuria aurantia
Fucα1-2Galβ-
Fucα1-6GlcNAcβ-
Fucα1-3GlcNAcβ-
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70% eluent B in the next 10 min, followed by an isocratic
elution with 70% eluent B for 5 min. The LC system was
coupled via an online nanospray source to an Esquire HCT
Ultra ESI-ion trap-MS (Bruker Daltonics). For electrospray
(1100–1250 V), stainless steel capillaries with an inner diam-
eter of 30 μm (Proxeon, Odense, Denmark) were used. The
dry gas temperature was set to 165 °C, and the nitrogen stream
was set to 7 l/min. The glycan spectra were acquired in
positive-ion mode and the mass spectrometer was carefully
tuned to minimize glycan decay in the ion transfer region,
thanks to the following settings: skimmer, 40 V; capillary exit,
106 V; octopole 1 DC, 6 V. The AA-labeled glycans were
analyzed using the data-dependent MS/MS mode over a
300–1500 m/z range. Five of the most abundant ions in an
MS spectrum were selected for MS/MS analysis by
collision-induced dissociation (CID). The LC-MS system
was tuned to minimize the effect of in-source decay of
sialylated structures as described previously [38].
Statistical methods
Unless otherwise indicated, the Student’s t-test was performed
to determine statistical significance between the average of 3
replicates.
Results
Initially, to check the effect of transfection on glycosylation
status in studied cells we analysed theMALDI-TOF-MS spec-
tra of parent and transfected cells (Supplementary Fig. 2). We
did not observe any significant effect of the transfection itself.
In further studies we used mock-transfected cell line as a neg-
ative control.
Characterization of N-glycan epitopes on membrane
and secreted proteins using plant lectins
As an initial characterization of the impact of upregulation of
GnT-III on the N-glycan repertoire in melanoma cells, we
evaluated the binding of selected plant lectins to membrane
and secreted glycoproteins blotted onto PVDFmembrane. We
chose an array of lectins recognizing most characteristic gly-
can epitopes (see Table 1). As the buffers used for extraction
of subcellular protein fractions were not compatible with any
of the protein assay, to avoid the effect of inequality of protein
load the lectin binding strength was calculated as a relative
optical density of all reactive protein bands in each lane with
the Coomassie Brilliant Blue (CBB) stained protein lanes as a
loading control. We observed similar lectin binding patterns in
the case of membrane and secreted proteins, suggesting a sim-
ilar glycosylation status of glycoproteins in both protein
groups. Overexpression of GnT-III did not appear to influence
the binding strength of SNA and MAA to membrane and
secreted proteins, suggesting no differences in the amount of
α2–6 and α2–3 sialylated glycans, respectively (Figs. 1 and
2). A similar observation was done in the case of GNA stain-
ing, recognizing high-mannose N-glycans (Figs. 1 and 2) and
AAA, which specifically binds to fucose (Figs. 1 and 2).
PHA-E staining (detecting Bbisecting^ GlcNAc) was signifi-
cantly increased in the case of both protein groups isolated
from WM266–4-GnT-III cells in comparison to control cells
(Figs. 1 and 2). Surprisingly, the staining pattern with PHA-L
(Figs. 1 and 2), which specifically recognizes β1–6 branching
of complex N-glycans was similar, suggesting an elevation of
PHA-L-reactive glycoproteins or glycans upon overexpres-
sion of GnT-III.
HILIC-HPLC analysis of N-glycans derived
from membrane and secreted proteins
To study the glycosylation changes upon GnT-III overexpres-
sion in more details, we performed HILIC-HPLC of 2-AA
labeled N-oligosaccharides derived from membrane and se-
creted proteins. In case of membrane protein-derived neutral
N-glycans the most abundant, both in case of transfected cells
and in the control, were 5 peaks a, b, d, e, f and g (Fig. 3a) with
GU values of 6.13, 7.00, 7.87, 8.72, 9.40 and 10.05, respec-
tively. Similarly, in case of secreted protein glycans, the most
intensive fluorescence represented peaks a, b, d, e, f with no
peak g present, but with additional peak c with GU of 7.43
(Fig. 3b). Overexpression of GnT-III caused the appearance of
additional peaks (Fig. 3), which in case of membrane proteins
have GU values of 6.78, 7.22 and 7.52 (peaks i, j and k,
respectively; Fig. 3a) and in case of secreted protein derived
glycans have GU values of 6.41, 6.76, 7.22, 7.53, 8.22 (peaks
h, i, j, k, and l, respectively, Fig. 3b). These additional peaks
represented approximately 9% of all neutral species from
membrane proteins, whereas in case of secreted proteins ap-
proximately 47% of all neutral oligosaccharides.
A similar analysis was made when it comes to negatively
charged N-glycans from both protein groups (Fig. 4). GnT-III
upregulation resulted in the appearance of additional peaks 13
and 14 with GU values of 8.39 and 9.07, respectively. The
relative abundance of these additional peaks represents
approx. 32% of all charged glycans in case of membrane pro-
teins, and approx. 12% of charged species from secreted
glycoproteins.
To elucidate the structures of glycans represented by select-
ed peaks, HILIC-HPLC analysis of glycan pools or collected
individual peaks treated with specific exoglycosidases was
performed (for enzymes used in the study see Table 2). After
digestion of neutral species with Aspergillus saitoi α1–2
mannosidase (ASM) the peaks b, d, e and f collapsed to a
single peak of 6.13 GU corresponding to MAN5, relying on
the ribonuclease B glycan library digestion as an external
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standard (Fig. 5a and b). Thus, the identity of the peaks b, d, e
and f as high mannose structures (MAN6, MAN7, MAN8 and
MAN9, respectively) was confirmed. The single peak specific
only for the membrane protein glycan fraction (peak g), was
also susceptible to ASM treatment and collapsed to a single
peak of 8.61 GU (Fig. 5a). This suggested the presence of the
terminal glucose on the MAN9 glycan (GlcMAN9) in this
case. To prove this, the peak was manually collected and treat-
ed additionally with rat liver α1–3 glucosidase II (RLG II),
and after digestion the GU shift from 10.05 to 9.40 (corre-
sponding to MAN9) was observed (Fig. 5c).
The peaks, that were characteristic only for transfected cells
(WM266–4-GnT-III) were also partially characterized with the
use of bovine testes β1-3-4 galactosidase (BTG), Arthrobacter
ureafaciensα2-3-6 sialidase (ABS) andASM.As themain 3 peaks
of neutral species (peaks i, j and k, Fig. 3) did not shift after
mannosidase treatment (Fig. 5a), they were probably complex N-
glycans. On the basis of the effect of BTGdigestion andGUvalues
of isolated peaks i and k, they were identified as diantennary
fucosylated structures with Bbisecting^ GlcNAc and one
(Hex4NexNAc5Fuc1-2-AA) or two terminal galactoses
(Hex5HexNAc5Fuc1-AA), respectively (Fig. 5d). In terms of
Fig. 1 Lectin detection of glycoproteins blotted on PVDFmembrane.
Membrane proteins (a) and secreted proteins (b) isolated from control
cells (1: WM266–4-pIRESneo) and GnT-III overepressing cells (2:
WM266–4-GnT-III) were resolved by SDS-PAGE and blotted
glycoproteins were probed with specific lectins (see Table 1). CBB –
Coomasie Brilant Blue-stained blot. As the buffers used for extraction
of subcellular protein fractions were not compatible with any of the
protein assay, the samples were prepared by volume and the optical
density of positive protein bands was than normalized to CBB staining
(Fig. 2)
Fig. 2 Relative optical density of lectin-positive glycoprotein bands
on PVDF membrane.Membrane proteins (a) and secreted proteins (b)
isolated of control cells (WM266–4-pIRESneo) and GnT-III
overepressing cells (WM266–4-GnT-III) were resolved by SDS-PAGE
and blotted glycoproteins were probed with specific lectins. Optical
density of each lane was measured and presented in relation to optical
density of loading control (CBB stained blots). Three independent
experiments were performed. Data are presented as means +/− standard
deviation (SD). Asterisk indicates statistically significant difference (*p <
0.05, ** p < 0.01; Student t-test)
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charged N-glycans of transfected cells the two characteristic peaks
(peak 13 and 14) both collapsed after ABS treatment and, on the
basis of their GU values they were annotated as diantennary
fucosylated structures with Bbisecting^ GlcNAc and one
(Hex5NexNAc5Fuc1Sia1-2-AA) or two (Hex5NexNAc5Fuc1Sia-
2-AA) terminal sialic acid residues (Fig. 5e).
Identification of N-glycans from membrane
and secreted proteins by mass spectrometry
2-AA labeled N-glycans from both cell lines and both protein
groups were further purified and analyzed by MALDI-TOF-
MS (Figs. 6 and 7). In addition, to elucidate structural features
of the N-glycans all 4 samples were studied by LC-ESI-ion
trap-MS/MS. The fragmentation spectra of selected N-glycans
are gathered in Supplementary Fig. 1. The glycans identifica-
tion was based on fragmentation of selected glycans and com-
mon knowledge of glycobiology. The Consortium for
Functional Glycomics (CFG) notation was used for the
schematic representation of N-glycans with in most cases no
specification of the linkage position in case of isomeric struc-
tures, unless indicated otherwise.
The structural annotation of glycans is summarized in
Supplementary Table 1. In general, 90 different N-glycan
structures were identified, with 29 of them present only in case
of WM266–4-GnT-III cells. Thus, the appearance of these
structures may be attributed to the overexpression of GnT-III
in melanoma cells. The major peaks within the N-glycans of
membrane proteins isolated from control cells were identified
as highmannose structuresMAN6,MAN7,MAN8 andMAN9
withm/z 1516.45,m/z 1678.55,m/z 1840.60 andm/z 2002.64,
respectively. This is consistent with the data from HILIC-
HPLC analysis, where these structures were also identified
as major peaks within the chromatogram (Fig. 5). Another
high mannose glycan was also identified at m/z 1354.39 as
MAN5, together with the monoglucosylated MAN9 glycan at
m/z 2164.72, in line with the results of the HPLC analysis
(Fig. 5). The sum of relative abundances of all high-
Fig. 3 HILIC-HPLC separation of neutral N-glycans. Membrane
proteins (a) and secreted proteins (b) of control cells (WM266–4-
pIRESneo) and GnT-III overepressing cells (WM266–4-GnT-III) were
deglycosylated and 2-AA labelled neutral glycans were separated on
TSKgel Amide-80 column. The major peaks are indicated with letters.
The black letters represent the peaks present in case of both cell lines, red
letters indicate peaks characteristic only for cells that overexpress GnT-
III. GU - glucose units
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mannose N-glycan peaks within the MALDI-MS spectrum of
membrane protein derived glycans was 58%. Additionally,
unusual small paucimannosidic structures with or without
core fucose were identified (eg. Hex4HexNAc2-AA and
Hex3HexNAc2dHex1-2-AA at m/z 1192.35 and m/z 1176.36,
respectively). Other major peaks that were observed in case of
the membrane protein fraction of control cells were at m/z
2051.69, m/z 2197.76, m/z 2488.92, m/z 2562.88, m/z
2854.07, m/z 2927.98, m/z 3145.19 and m/z 3219.15. These
peaks were mainly core-fucosylated complex N-glycans with
terminal sialic acid residues (1–3) and different number of N-
acetyllactosaminyl (LacNAc) units or antennae (2–4)
(Supplementary Table 1), and the sum of their relative abun-
dances within the spectrum was 23%. Among these glycans,
the peak at m/z 3145.19 was annotated as triantennary struc-
tu re conta in ing 3 te rmina l s ia l i c ac id res idues
(Hex6HexNAc5dHex1NeuNAc3-AA). Another peak with 3
or 4 LacNAc units can represent either tri- or tetra-antennary
glycans or diantennary structures with poly-LacNAc exten-
sions of the antennae. Taking into account the MS/MS data
we observe in these cases clear intensive signals at m/z 366.0
[M + H]+ (Hex1HexNAc1) and m/z 657.2 [M + H]
+
(Hex1HexNAc1NeuNAc1) indicating the presence of individ-
ual antennae (see spectra 41–48 in Supplementary Fig. 1).
Moreover, in the case of all the large structures, the fragmen-
tation spectra did not contain oxonium ions which would
Fig. 4 HILIC-HPLC separation of negatively charged N-glycans.
Membrane proteins (a) and secreted proteins (b) of control cells
(WM266–4-pIRESneo) and GnT-III overepressing cells (WM266–4-
GnT-III) were deglycosylated and 2-AA labelled charged glycans were
separated on TSKgel Amide-80 column. The major peaks are indicated
with numbers. The black numbers represent the peaks present in case of
both cel lines, red numbers indicate peaks characteristic only for cells that
overexpress GnT-III. GU - glucose units
Table 2 List of
exoglycosidases used to
study the structures of N-
glycans byHILIC-HPLC
Exoglycosidase source Abbreviation
α1-2 mannosidase
Aspergillus saitoi
ASM
β3-4 galactosidase
bovine testes
BTG
α,1-3 glucosidase II
rat liver
RTG
α2-3-6 sialidase
Arthrobacter ureafaciens
ABS
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suggest the presence of poly-LacNAc extensions of the
b ranches ( e .g . compos i t i ons Hex2HexNAc2 or
Hex2HexNAc2NeuNAc1). Basing on these observation, we
can safely conclude, that in these cases we observed tri- and
tetraantennary complex structures rather than diantennary N-
glycans with LacNAc repeats. In terms of secreted proteins
fraction of control WM266–4-pIRESneo cells, the major
peaks within the N-glycan profile did not represent high-
mannose species. Seven major peaks were present, with the
predominant signals at m/z 2198.01 (approx. 31% of all gly-
cans) and m/z 2489.19 (approx. 15% of all glycans), which
were identified as core fucosylated diantennary complex
structures with one (Hex5HexNac4dHex1NeuNAc1-AA) and
two (Hex5HexNAc4dHex1NeuNAc2-2-AA) terminal sialic
acids, respectively. The other structures were identifiedmainly
as complex glycans with core fucose, terminal sialic acid res-
idues and a different number of LacNAc units, similarly as in
the case of membrane protein fraction. Along with these main
peaks, also some weaker signals were detected, both in case of
membrane and secreted protein-derived glycans, mainly as
fucosylated complex structures with a different number of
terminal sialic acids (1–3) and LacNac units (4–6) (Figs. 6
and 7 and Supplementary Table 1). These peaks were present
atm/z 3510.57,m/z 3584.16 andm/z 3658.20. Finally, we also
observed an unusual core-fucosylated MAN5 N-glycan at m/z
1500.54 within the membrane protein-derived fraction.
GU 6,13
GU 8,61
ASM
6 7 8 9 10
UND
a
GU
GU 6,13
GU 7,00
GU 7,84 GU 8,72
GU 9,40
GU 6,13
ASM
6 7 8 9 10
UND
b
GU
GU 9,40
ASM
RLG II
7 8 9 10 11 12
UND
GU
c
GU 6.13
GU 6.76
BTG
GU 7.53
GU 6.13
BTG
UND
d
UND
GU 7.52
13
14
ABS
ABS
UND
UND
GU 8.39
GU 9.07
e
GU 8,61
GU 7.54
Fig. 5 HILIC-HPLC characterisation of selected neutral and
charged N-glycan peaks from WM266–4-GnT-III cells. Proteins
were deglycosylated and 2-AA labelled N-glycans were separated on
TSKgel Amide-80 column before and after digestion with
exoglycosidases (see Table 2). Panel a represents the effect of neutral
N-glycan pool treated with α1–2 mannosidase (ASM). Panel b shows
the effect of digestion of ribonuclease B high mannose glycan standard
with ASM. PanelC represents the effect of ASM andα1–3 glucosidase II
(RLGII) treatment on isolated peak g. Panel d represents the effect ofβ1–
3,4 galactosidase (BTG) treatment on isolated peaks i and k. Panel e
represents the effect of α2-3-6 sialidase (ABS) treatment on isolated
peaks 13 and 14. UND – undigested, GU - glucose units
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The overexpression of GnT-III in these melanoma cells
resulted in the appearance of 29 N-glycans, which were not
observed in case of control cells. Most of them were
Bbisected^ structures and were present both within membrane
protein-derived N-glycans as well as secreted protein-derived
fraction. The presence of the Bbisecting^ GlcNAc residue was
in majority of cases confirmed in fragmentation spectra and
the fragment ions at m/z 911.4 [M + H]+ (H1N3-AA), m/z
1056.4 [M + H]+ (H1N3Fuc1-AA) and m/z 1276.6 [M +
H]+ (H2N4-AA) were indicative in this case (Supplementary
Fig. 1, Supplementary Table 2). The major signal, which is
strongly upregulated in the transfectants was observed at m/z
2400.7 and identified as diantennary fucosylated complex
structure with single terminal sialic acid residue and
Bbisecting^ GlcNAc (Hex5HexNAc5dHex1NeuNAc1-2-AA)
(Supplementary Table 1, Figs. 6 and 7). The relative abun-
dance of this oligosaccharide is approximately 15% of
membrane-derived N-glycans and about 23% for the secreted
protein-derived fraction. Other major peaks were identified as
Bbisected^ diantennary glycans with or without core fucose
and with different length of the antennae. Interestingly, the
addition of the Bbisecting^ GlcNAc as a result of GnT-III
overexpression also occurred in case of hybrid glycans, and
4 different species were identified at m/z 1922.5, m/z 2068.6,
m/z 2213.6 and m/z 2359.7 (Hex6HexNAc4 with or without
sialic acid, and with or without core fucose). Finally, the ad-
dition of Bbisecting^ N-acetylglucosamine in WM266–4-
GnT-III cells involved also N-glycans containing more than
two LacNAc repeats. The major peaks within this group of
o l i gosaccha r i de s we re de t e c t ed a t m/z 2474 .7
( H e x 6 H e x N A c 6 d H e x 1 - A A ) , m / z 2 7 6 5 . 8
(Hex6HexNAc6dHex1NeuNAc1-AA), m/z 3056.9
(Hex6HexNAc6dHex1NeuNAc2-AA), m/z 3130.9
(Hex7HexNAc7dHex1NeuNAc1-AA) and m/z 3422.0
(Hex7HexNAc7dHex1NeuNAc2-AA). These can be identified
as Bbisected^ tri- or tetraantennary complex structures from
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Fig. 6 Negative ionmodeMALDI-TOF-MS spectra of AA-labeledN-
glycans released from membrane proteins of WM266–4-pIRESneo
(a) and from WM266–4-GnT-III (b) melanoma cells. Proposed
composition of the N-glycan structures deduced from the MALDI-TOF-
MS and LC-ESI-ion-trap-MS/MS are listed in supplementary Table 1.
Only major structures are depicted. Only the m/z values which are
considered as an transfection effect are annotated in b. In some cases
structural isomers are possible. Fucose linkage is specified only in cases
where LC-ESI-ion-trap-MS/MS gives evidence. Glycan schemes were
prepared using GlycoWorkbench. The spectra and m/z values obtained
in the MALDI-TOF linear mode are presented here. Red triangle, fucose;
yellow circle, galactose; green circle, mannose; blue square,
N-acetylglucosamine; purple diamond, sialic acid
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the similar reason as in case of control cells and all of them
were characteristic for both membrane and secreted protein-
derived glycans. Interestingly, in both cases we also identified
trisialylated structures: triantennary Bbisected^ glycan at m/z
3348.2 (Hex6HexNAc6dHex1NeuNAc3) and tri- or
tetraantennary Bbisected^ structure at m/z 3713.2
(Hex7HexNAc7dHex1NeuNAc3-2-AA) among secreted
protein-derived glycans. Some other of the identified N-
glycans were present only in case of one of the protein frac-
tions. For example, an interesting Bbisected^ glycan at m/z
2645.8 (Hex4HexNAc7dHex3-AA), were found only in case
of the secreted protein fraction (Supplementary Table 1). By
contrast, two highly branched complex structures with poly-
LacNAc extensions and Bbisecting^ GlcNAc were found at
m/z 3787.1 (Hex8HexNAc8dHex1NeuNAc2-AA) and m/z
3861.2 (Hex9HexNAc9dHex1NeuNAc1-AA) only in case of
the membrane protein-derived N-glycans (Supplementary
Table 1).
Finally, we also observed peaks satellite to some
sialylated complex N-glycans and basing on the mass
shift of 18 Da we identified them as structures containing
l a c t on i z ed N - a c e t y l n e u r am in i c a c i d r e s i d u e s
(NeuNAcLac) (Figs. 6 and 7 and Supplementary
Table 1). As the internal esterification concerns α2-3-
l i nked s i a l i c ac id , t he g lycans a t m/z 2197 .6
(Hex5HexNAc4dHex1NeuNAc1-2-AA), m/z 2400.7
(Hex5HexNAc5dHex1NeuNAc1-2-AA), m/z 2488.8
(Hex5HexNAc4dHex1NeuNAc-2-AA), m/z 2691.8
(Hex5HexNAc5dHex1NeuNAc2-2-AA), m/z 2853.9
(Hex6HexNAc5dHex1NeuNAc-2-AA) and m/z 3056.9
(Hex6HexNAc6dHex1NeuNAc2-2-AA) were identified as
containing at least one terminal α2-3-linked NeuNAc.
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Fig. 7 Negative ionmodeMALDI-TOF-MS spectra of AA-labeledN-
glycans released from proteins secreted by WM266–4-pIRESneo (a)
and WM266–4-GnT-III (b) melanoma cells. Proposed composition of
theN-glycan structures deduced from theMALDI-TOF-MS and LC-ESI-
ion-trap-MS/MS are listed in supplementary Table 1. Only major
structures are depicted. Only the m/z values which are considered as an
transfection effect are annotated in b. In some cases structural isomers
are possible. Fucose linkage is specified only in cases where LC-ESI-ion-
trap-MS/MS gives evidence. Glycan schemes were prepared using
GlycoWorkbench. The spectra and m/z values obtained in the MALDI-
TOF linear mode are presented here. Red triangle, fucose; yellow circle,
galactose; green circle, mannose; blue square, N-acetylglucosamine;
purple diamond, sialic acid
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Discussion
N-Acetylglucosaminyltransferase III (GnT-III) catalyzes the
synthesis of Bbisected^ N-glycan structures by the transfer of
a single GlcNAc residue to the β-mannose of the core. This
reaction is one of the critical steps of the glycosylation path-
way, and the resulting Bbisecting^ GlcNAc has unique fea-
tures among all other N-glycans modification. First of all, in
contrast to other GlcNAc branches, it is not further elongated
by other transferases [6]. Secondly, in terms of the topography
of glycosylation machinery within Golgi apparatus, the action
of GnT-III is very often considered as a Bstop^ signal because
the presence of its product prevents the action of other
GlcNAc transferases such as GnT-II, IV and V but also core
α1-6 fucosyltransferase andαmannosidase II [39]. This gives
the enzyme the potency to be a kind of a Bswitcher^, which
through the changes of its expression level and the activity,
could regulate the formation of complex N-glycan structures
of the cellular glycoproteins. Thus, the biological role of GnT-
III is under intensive investigation, partially in terms of its
impact on cancer cell behavior.
Previously, we described the melanoma cellular model, in
which WM266–4 metastatic melanoma cells were stably
transfected withMAGT3 gene [28]. Although the upregulation
of GnT-III is functional because it has resulted in the modifica-
tion of Melanoma Cell Adhesion Molecule (MCAM) glycans
by introducing Bbisecting^ GlcNAc residue, it has not signifi-
cantly influenced the transendothelial invasiveness of the cells
in vitro. The WM266–4 melanoma cell line was chosen as a
transfection host partially because it was described as express-
ing a high level of highly branched oligosaccharides (tri- and
tetraantennary N-glycans) [40]. The aim of the present study
was to characterize in detail the influence of GnT-III overex-
pression on the N-glycan repertoire of membrane and secreted
proteins in these metastatic melanoma cells. We usedWM266–
4-pIRESneo cells as a transfection control and WM266–4-
GnT-III cell line as a model of GnT-III overexpression [28].
The stronger reaction of glycoproteins with PHA-E upon
GnT-III overexpression is a logical consequence of the en-
zyme upregulation and is usually treated as a positive control
of successful transfection of cells [7, 8, 41, 42]. Surprisingly,
we did observe also stronger staining with PHA-L, which
would suggest that GnT-III up-regulation led also to the ele-
vation of β1–6 branching of complex N-glycan structures.
This remains in contrast to the fact, that action of GnT-III is
considered as inhibitory towards GnT-V enzyme, which was
observed by weakened PHA-L staining in many cases of
MGAT3 transfectants [7, 13, 43]. To our knowledge, this re-
port together with our previous studies [28] are the only de-
scriptions of elevated PHA-L staining of glycoproteins upon
GnT-III overexpression. The one explanation for this phenom-
enon is the possible influence of GnT-III on the GnT-Vactivity
or its expression level. However, previously we showed no
impact of MGAT3 transfection either on the expression of
GnT-V nor its activity in vitro [28]. The other possible expla-
nation is that the introduction of Bbisecting^ GlcNAc residues
causes more global glycomic effects, which in turns changes
the binding interactions of some previously existing N-
glycans structures with PHA-L. To investigate this effect, we
performed detailed glycomic analysis of N-glycans isolated
from cellular glycoproteins of studied cells.
The elevated presence of Bbisected^ biantennary glycans,
which we observed in case of GnT-III overexpressing
WM266–4-GnT-III cells, has been often described as the re-
sult of GnT-III overexpression, but there are not many detailed
descriptions of glycomic changes in these cases. Ihara et al.
showed the appearance of diantennary structure with
Bbisecting^ GlcNAc residue on serum glycoproteins in GnT-
III transgenic mouse [41]. Koyota et al. presented the upreg-
ulation of Bbisected^ diantennery oligosaccharides in swine
endothelial cells overexpressing GnT-III with the simulta-
neous down regulation of tri- and tetraantennary sugars [44].
In terms of cancer biology, the biological function of such
modifications of cellular glycome has been described mainly
as modulator of cellular migration and invasiveness. In the
light of these data, GnT-III indeed can act as a metastasis
inhibitor, but in the majority of published cases, this effect is
linked to the simultaneous, almost total down-regulation of N-
glycan branching as a result of competition between GnT-III
and GnT-V for an acceptor substrate.
Interestingly, our data show that besides the diantennary
glycans, into which the Bbisecting^ GlcNAc is introduced
upon GnT-III overexpression, other types of glycans are mod-
ified in this manner as well. In case of branched Bbisected^
structures, one triantennary and one at least triantennary
sialylated complex glycans were identified at m/z 3348.2
(Hex6HexNAc6dHex1NeuNAc3) and m/z 3713.2
(Hex7HexNAc7dHex1NeuNAc3-2-AA), respectively. Adding
to that, a broad group of Bbisected^ N-glycans containing
LacNAc units were annotated, starting from simple core
fucosylated and non-sialylated structure at m/z 2474.8
(Hex6HexNAc6dHex1-2-AA) up to mono sialylated oligosac-
charide containing six LacNAc units at m/z 3861.2
(Hex9NeuNAc9dHex1NeuNAc1-2-AA). Basing onmass anal-
ysis and fragmentation data it was not possible here to make a
clear distinction between highly branched structures and
diantennary glycans with poly-LacNAc extensions.
However, as the LC-ESI-ion trap-MS data indicates a high
level of sialylation and the fragmentation spectra do not give
an evidence for the presence of LacNAc repeats in studied
samples, it is more likely that the multiantennary N-glycans
prevail. Adding to that, Kinoshita et al. have described a
glycome of WM266–4 melanoma cells which we used as a
transfection host, as containing a high amount of tri- and tetra-
antennary complex N-glycans [45]. Basing on mass analysis,
our results concerning the glycosylation of control cells
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(WM266–4-pIRESneo) are in line with these data. In case of
the transfectants (WM266–4-GnT-III cells), we presume that
these highly branched N-glycans were also modified by GnT-
III. It is evidently visible when comparing the MALDI-TOF
spectra of control and transfected cells, while there is a signif-
icant shift of main peaks (besides high mannose glycans) of
the constant value of m/z 203, which corresponds to a single
GlcNAc residue (Figs. 6 and 7).
The presence of Bbisecting^ GlcNAc in the tri- and tetra-
antennary glycans is very unusual, because of the ability of
this modification to block the activity of other GlcNAc trans-
ferases, which was mentioned above [46]. A few years ago
Klisch et al. described the high content of tri- and tetra-
antennary, core fucosylated N-glycans containing Bbisected^
GlcNAc on pregnancy-associated glycoproteins (PAGs) in ru-
minants [47]. The occurrence of such structures could be the
result of the specific spatial distribution of glycosyltransfer-
ases within the Golgi compartments. The introduction of sin-
gle GlcNAc residue to the β-mannose of the core of highly
branched structures would be enabled by the localization of
GnT-IVand -Vearlier within the secretory pathway than GnT-
III. Interestingly, it was proved, that caveolin-1 by forming
complexes with GnT-III can act as a regulator of its distribu-
tion within the Golgi [48]. The expression of caveolin-1 in
melanoma cells has been studied by Bełkot et al., and their
work showed that in case of WM266–4 melanoma cells its
expression is relatively low and the distribution within the
cells do not show localization of the protein in ER and Golgi
apparatus [49]. It is possible, that in WM266–4-GnT-III mel-
anoma cells studied here, the level of caveolin-1 is thus too
low to localize GnT-III in the early compartments of the se-
cretory pathway. From the other hand, we observe the pres-
ence of hybrid, Bbisected^ glycans, which formation probably
occurs within the early Golgi and could be the effect of α
mannosidase II inhibition by GnT-III product [50].
In case of melanoma model described here, GnT-III action
seems to involve almost all hybrid and complex N-glycans
regardless of their molecular mass, leading to a broad glycomic
effect. But, the mechanisms and biological consequences of
such modification remains challenging to study in detail, par-
tially because themutual interplay of glycosyltransferases with-
in secretory pathway is still a puzzle. First of all, an ambiguous
picture of the role of Bbisected^ N-glycans in cancer allows to
raise the assumption, that the cellular context (for example
overall levels of different branching glycosyltransferases)
may contribute to determining structure and function of
Bbisected^ glycans [51]. There is also growing number of ev-
idence that glycosyltransferases can form homomers and
heteromers, and the balance of the formation of these species
can influence the activity of the enzymes itself [52]. The ele-
vated reactivity of cellular glycoproteins with PHA-L that we
observe here is for sure the consequence of elevated GnT-III
action in the cells. It is known, that the introduction of
Bbisecting^ GlcNAc residue changes the spatial shape of N-
glycans and thus can modulate its biological properties [4]. A
single sugar substitution of the N-glycan core is especially
studied in this context, giving evidence that Bbisecting^
GlcNAc and core fucose can be treated as molecular switches
of conformational behaviour of glycan structures [53].
Recently, it has been shown, that Bbisecting^ GlcNAc can re-
strict the conformers of branched structures by the formation of
the ‘back-fold’ conformation [54]. As a consequence, the gly-
can binding to specific lectin can be changed. It is possible that
the stronger binding of glycoproteins from WM266–4-GnT-III
cells to the PHA-L is the result of a conformational change
made by the introduction of Bbisecting^ GlcNAc into highly
branched structures, which leads to the promotion of PHA-L
binding. It cannot be excluded, that similar modifying effect as
a result of GnT-III overexpression would be observed in mela-
noma cells in vivo, if other carbohydrate-protein interactions
were taken into account. In case of branched glycans the studies
concerning their interactions with mammalian lectins are how-
ever limited [55]. But, the potential of Bbisecting^ GlcNAc to
be a modificator of these interactions seems to be worth to
consider, as we know, for example, that mouse dendritic cell
inhibitory receptor 2 (mDCIR2) recognizes not only the α1–3
branch but also a Bbisecting^ GlcNAc residue of diantennary
complex glycans [56].
To conclude, our studies provide the detailed glycomic data
of the effect of GnT-III overexpression in melanoma cells. We
showed that the enzyme can modify highly-branched N-gly-
cans by the introduction of the Bbisecting^ GlcNAc residue. It
probably strengthens the binding capacity of some of these
structures to PHA-L, which is the phenomenon that has not
been described so far. Our results suggest the need for further
studies of PHA-L binding specificity towards different types
of complex N-glycans. Moreover, in our opinion, the
glycomic effect seen here could lead to the changes of other
protein-carbohydrate interactions, also in vivo. Thus, it would
be important to study the biological impact of introducing of
the Bbisecting^ GlcNAc residue into complex N-glycans on
their biological function, for example, specificity toward
glycan-binding proteins, especially in the context of cancer
cell biology.
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